The Peptide Report
A quiet shift is happening in the upper ranks of Silicon Valley: high-performing executives are trading traditional sleep aids for doctor-formulated nasal sprays. Here's the science behind the trend.
The afternoon cognitive crash plaguing knowledge workers isn't a caffeine problem — it's a mineral problem. Here's why high-output professionals are quietly stacking potassium, magnesium, and zinc.
Melatonin built the modern sleep aid market—and then the people who depend most on cognitive recovery quietly walked away from it. Here's what they're using instead, and why doctor-formulated sleep stacks have become the new standard in performance circles.
American companies lose billions annually to the universal mid-afternoon cognitive crash. A quiet cohort of executives is replacing the third espresso with something faster, cleaner, and built for sustained focus.
The 3PM energy collapse isn't a caffeine problem—it's a cellular one. Inside the quiet shift in Silicon Valley wellness routines, and the science of mitochondrial support.
A quiet cohort of operators has retired the afternoon espresso in favor of a peptide-based nasal spray. Here's what the science says — and why it matters in 2026.
